Table: Fractale -2020/21 group results

ADR Biomedical Holdings

14/05/2021 08:00

May 14 (Reuters)- 
          Fractale Corporation 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended        Year to        NEXT   
               Mar 31, 2021    Mar 31, 2020    Mar 31, 2022      YEAR     
                  LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS          RESULTS        FORECAST     H1 FORECAST 
  Sales            1.39            1.18            2.00                   
               (+17.6 pct)      (-38.7 pct)     (+44.1 pct)               
  Operating    loss 731 mln    loss 129 mln    loss 180 mln               
  Recurring    loss 745 mln    loss 185 mln    loss 280 mln               
  Net                                          loss 165 mln               
  Net          loss 831 mln       319 mln                                 
                                (-46.1 pct)                               
  EPS        loss 101.64 yen     47.58 yen    loss 18.94 yen              
  Ann Div          NIL           10.00 yen                                
  -Q2 Div          NIL              NIL                                   
  -Q4 Div          NIL           10.00 yen                                
  
  NOTE - Fractale Corporation.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T